GR class I&II, n = 57 | Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|---|
Hr | 95% CI Lower | 95% CI Upper | p-value | HR | 95% CI Lower | 95% CI Upper | p-value | |
Age | 1.03 | 1.005 | 1.06 | 0.017 | n.s. | |||
PTA pre treatment | 1.072 | 1.04 | 1.11 | < 0.001 | 1.081 | 1.045 | 1.118 | < 0.001 |
Tumor diameter CPA (cm) | 0.72 | 0.47 | 1.12 | 0.15 | n.s. | |||
Tumor diameter IAC (cm) | 2.70 | 0.93 | 7.85 | 0.07 | n.s. | |||
Tumor Volume pre- treatment (ml) | 0.94 | 0.86 | 1.03 | 0.17 | n.s. | |||
Dose scheme (0 = fract, 1 = rs) | 2.05 | 1.01 | 4.17 | 0.05 | n.s. | |||
Max cochlear dose EQD2a | 1 | 1 | 1 | 0.99 | n.s. | |||
Mean cochlear dose EQD2a | 1 | 1 | 1 | 0.58 | n.s. | |||
V90 cochlea EQD2 b | 1.01 | 1.00 | 1.013 | 0.027 | 1.011 | 1.004 | 1.017 | 0.001 |
Cochlear volume (ml) | 1.0 | 0.99 | 1.003 | 0.26 | n.s. | |||
time-to-first-audiogram (after treatment) | 1.0 | 0.95 | 1.04 | 0.85 | n.s. |